Mercer Global Advisors
LLY icon

Mercer Global Advisors’s Eli Lilly LLY Stock Holding History

Mercer Global Advisors’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-115,039
Closed -$88.2M – 2697
2025
Q2 		$88.2M Buy
+115,039
New +$89.4M 0.18% 74

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Mercer Global Advisors's LLY Position: Q1 2026 in Review

Mercer Global Advisors increased its Eli Lilly (LLY) stake by 30% in Q1 2026, buying an estimated $41.2M and bringing the position to 175,063 shares worth $161M. The position accounts for 0.24% of the portfolio, ranked #54.

Mercer Global Advisors first reported a position in LLY in Q1 2019 and has held it in 28 quarters since. The position peaked at $628M in Q2 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Mercer Global Advisors held 175,063 shares of Eli Lilly worth $161M as of Q1 2026.
  • Mercer Global Advisors bought 40,673 Eli Lilly shares in Q1 2026, an estimated $41.2M.
  • Eli Lilly made up 0.24% of Mercer Global Advisors's portfolio in Q1 2026, its #54 holding.
  • Mercer Global Advisors first reported a position in Eli Lilly in Q1 2019 and has held it in 28 quarters since.
  • Mercer Global Advisors's Eli Lilly position peaked at $628M in Q2 2024.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Mercer Global Advisors's 13F filing for Q1 2026, filed 15 May 2026.